Arterial Remodeling Technologies has reported positive results of its biodegradable stent from first-in-human Arterial Remodeling Transient DIsmantling Vascular Angioplasty (ARTDIVA) study. The bioresorbable stent, which promotes ...
Tags: clinical trial, clinical technology, clinical research
NuVasive has gained premarket approval (PMA) for its cervical motion preserving system from the US Food and Drug Administration (FDA). The PCM cervical disc device, which is comprised of superior and inferior endplates, is designed for ...
Tags: cervical motion preserving system, PCM cervical disc device, FDA
Cardinal Health has entered into an agreement to manufacture and distribute Eli Lilly and Company's new diagnostic imaging agent, Amyvid, at seven sites throughout the US. Amyvid, a radioactive diagnostic agent, tagged with a ...
Inscopix, a provider of in vivo cellular imaging solutions, and SRI International have entered into a collaboration agreement on neuroscience imaging R&D program. Under the agreement, SRI's Center for Neuroscience and Metabolic ...
Tags: company cooperation, clinical research, clinical technology
SRI International has received a new grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a topical microbicide gel for drug delivery. The topical microbicide gel, which will be based on a patented ...
The Carol and Ray Neag Comprehensive Cancer Center and Christiana Care Helen F. Graham Cancer Center have ordered for RaySearch Laboratories' RayStation treatment planning system. The Carole Cancer Center will use RayStation for ...
Tags: clinical research, clinical technology, RaySearch, RayStation
Paris based cancer center Institut Curie has ordered four radiotherapy treatment systems - three Varian TrueBeam systems and a Novalis Tx machine - from Varian Medical Systems. The cancer institute has purchased the devices to replace ...
Tags: radiotherapy treatment system, medical device, clinical research
Magdeburg-based Dornheim Medical Images has said that three-dimensional images facilitate medical diagnoses. Dornheim's program, designed for creating three-dimensional images, uses cross-sectional images and the highlighted areas of ...
Tags: clinical research, clinical application, clinical technology
Affibody has entered into a collaboration agreement with GE Healthcare to develop a Her2-targeted PET imaging agent for detecting breast and gastric cancer. The clinical trials for the Her2-targeted PET imaging agent is scheduled to ...
Tags: company cooperation, clinical research, breast cancer, gastric cancer
GeNO has received four additional US patents for its proprietary nitric oxide (NO) generation chemistry and delivery technology. The patent No. 8,211,368 describes the conversion of nitrogen dioxide (NO2) to NO where NO2 is stored as ...
Tags: US patent, clinical technology, clinical research, GeNO
Allegro Diagnostics has completed patient enrollment in 1,320-patient Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer II (AEGIS II) trial for BronchoGen genomic test. BronchoGen, which is built on the company's ...
Tags: clinical trial, clinical research, lung cancer molecular diagnostic
Cytori Therapeutics, a developer of cell therapies based on autologous adipose-derived regenerative cells (ADRCs), has obtained Russian approval for its Celution 800 system. The Celution system and its related products including ADRCs ...
Tags: cell therapy, Celution 800 system, clinical product, clinical research
Nipro has entered into a five-year agreement to distribute Infraredx's TVC intravascular imaging system for true vessel characterization of coronary artery disease in Japan. The TVC imaging system incorporates near infrared ...
The US Patent and Trademark Office (USPTO) will issue Patent No. 8,340,916 to Sequenom for its application covering methods of detecting fetal aneuploidy. The patent, which will be issued on 25 December 2012, covers claims related to ...
Tags: Sequenom, US patent, fetal aneuploidy, USPTO
The US Food and Drug Administration (FDA) has accepted Avanir Pharmaceuticals' investigational new drug (IND) application for the study of AVP-923, an investigational drug for the treatment of agitation in patients with Alzheimer's disease. ...
Tags: AVP-923, Alzheimer's disease, IND